Small-scale studies in overweight or obese populations have reported that acute infusion of PYY3–36 can lead to modest improvements in oral glucose tolerance and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) [67]. This evidence concerns the gene PYY3 and Insulin resistance.